<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000819'>Diabetes mellitus</z:hpo> (DM) in adults is a global health problem, although its prevalence varies widely between different populations and the rate has generally increased worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>In Taiwan, the mortality rate from DM has almost doubled over the past 10 years </plain></SENT>
<SENT sid="2" pm="."><plain>The prevalence of DM in Taiwan was established between 1985 and 1996 and the rates were between 4.9 and 9.2% </plain></SENT>
<SENT sid="3" pm="."><plain>The prevalence of <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) was 15.5% (men 15% and women 15.9%) </plain></SENT>
<SENT sid="4" pm="."><plain>The prevalence of DM and IGT increased significantly with age for both genders </plain></SENT>
<SENT sid="5" pm="."><plain>The significant factors associated with newly diagnosed DM were age, BMI, family history of DM, systolic blood pressure (<z:hpo ids='HP_0000822'>hypertension</z:hpo>), physical activity and serum <z:chebi fb="0" ids="17855">triglyceride</z:chebi> levels </plain></SENT>
<SENT sid="6" pm="."><plain>The prevalence of large vessel disease (LVD) in DM and non-diabetic subjects were 20.0 and 12.9%, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Among diabetics, 15.8% had <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e>), 1.7% leg vessel disease (leg VD), and 2.5% <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>In non-diabetics, the prevalence of the aforementioned <z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathies</z:e> were 11.5, 0.2 and 1.2%, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>The diabetics had a significantly higher prevalence of macrovascular disease than non-diabetic subjects </plain></SENT>
<SENT sid="10" pm="."><plain>The most significantly associated with the LVD was serum cholesterol levels </plain></SENT>
<SENT sid="11" pm="."><plain>Serum cholesterol and HbA1(c) were significantly associated with the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Cigarette smoking and female gender were significantly associated with the leg VD </plain></SENT>
<SENT sid="13" pm="."><plain>The prevalence of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (DR) was 35.0% </plain></SENT>
<SENT sid="14" pm="."><plain>(background DR 30%, preproliferative DR 2.8% and proliferative DR 2.2%, respectively.) The prevalence of DR for previously and newly diagnosed diabetics were 45.2 and 28.3% (men 42.8 vs. 33.3% and women 47.5 vs. 24.8%), respectively </plain></SENT>
<SENT sid="15" pm="."><plain>From multiple logistic regression analysis, duration of DM was the most important risk factor related to DR </plain></SENT>
<SENT sid="16" pm="."><plain>Diabetic subjects treated with insulin had a higher risk of developing <z:hpo ids='HP_0000488'>retinopathy</z:hpo> than those treated with dietary control </plain></SENT>
<SENT sid="17" pm="."><plain>The prevalence of <z:hpo ids='HP_0000112'>nephropathy</z:hpo> and <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> were 12.9 and 23.5%, respectively </plain></SENT>
<SENT sid="18" pm="."><plain>For those patients with and those without <z:hpo ids='HP_0000112'>nephropathy</z:hpo> and <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e>, the duration of DM, percentage of insulin treatment, percentage of <z:hpo ids='HP_0000822'>hypertension</z:hpo>, and fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> were significantly different </plain></SENT>
<SENT sid="19" pm="."><plain>Diabetic duration, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, insulin treatment and glycemic control consistently correlated with <z:hpo ids='HP_0000112'>nephropathy</z:hpo> and <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> </plain></SENT>
<SENT sid="20" pm="."><plain>In conclusion, the prevalence of DM in Taiwan was between 4.9 and 9.2%, and the prevalence of IGT was 15.5% </plain></SENT>
<SENT sid="21" pm="."><plain>The possible risk factors of newly diagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> were age, family history of DM, BMI, SBP (<z:hpo ids='HP_0000822'>hypertension</z:hpo>), physical activity and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> levels </plain></SENT>
<SENT sid="22" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp> in Chinese subjects share many characteristics similar to other Asian populations </plain></SENT>
<SENT sid="23" pm="."><plain>The burden imposed by the <z:hpo ids='HP_0011010'>chronic</z:hpo> complications of <z:mp ids='MP_0002055'>diabetes</z:mp> is massive </plain></SENT>
<SENT sid="24" pm="."><plain>In Taiwan, the mortality rates from DM have increased greatly over the past 10 years </plain></SENT>
<SENT sid="25" pm="."><plain>Reduction of the modificable risk factors such as BMI, hypertenion and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, and increase of physical activity and good glycemic control through public health efforts may help to reduce the risk of DM and its <z:hpo ids='HP_0011010'>chronic</z:hpo> complications </plain></SENT>
</text></document>